Literature DB >> 19369685

Interaction between parathyroid hormone and the Charlson comorbidity index on survival of incident haemodialysis patients.

Luigi Francesco Morrone1, Sandro Mazzaferro, Domenico Russo, Filippo Aucella, Mario Cozzolino, Maria Grazia Facchini, Andrea Galfrè, Fabio Malberti, Maria Cristina Mereu, Maurizio Nordio, Giovanni Pertosa, Domenico Santoro.   

Abstract

BACKGROUND: Haemodialysis patients are ageing and have with a high rate of comorbidities. The impact of this novel clinical setting on intact parathyroid hormone (iPTH) is not well established.
METHODS: For this observational, prospective multicentre cohort study, incident haemodialysis patients were recruited in 40 Italian centres and followed up for a mean period of 18 +/- 6.7 months. Clinical characteristics and biochemistry were recorded at baseline. Comorbid conditions were scored by the Charlson comorbidity index (CCI).
RESULTS: Data of 411 patients (mean age: 66.5 +/- 14.8 years; 17.3% >80 years old) were recorded. The mean CCI was 4.17 +/- 2.8. In patients with CCI >0, an inverse correlation was observed between CCI (excluding age) and iPTH (P = 0.00002). Independently of CCI, patients with iPTH <150 pg/ml had 76% as high as the risk of all-cause mortality. After multivariable adjustment, the combination of the first tertile of iPTH with second and third tertiles of CCI was significantly associated with all-cause mortality (RR = 3.83, P = 0.02; RR = 3.79, P = 0.01, respectively).
CONCLUSIONS: Incident haemodialysis patients suffer from a high rate of clinical complications. In these patients, low iPTH and high CCI are often associated and very likely responsible for an adverse outcome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369685     DOI: 10.1093/ndt/gfp170

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

Review 1.  Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology.

Authors:  Luigi Francesco Morrone; Pergiorgio Bolasco; Corrado Camerini; Giuseppe Cianciolo; Adamasco Cupisti; Andrea Galassi; Sandro Mazzaferro; Domenico Russo; Luigi Russo; Mario Cozzolino
Journal:  J Nephrol       Date:  2016-04-09       Impact factor: 3.902

2.  Diagnostic Workup for Disorders of Bone and Mineral Metabolism in Patients with Chronic Kidney Disease in the Era of KDIGO Guidelines.

Authors:  Luigi Francesco Morrone; Domenico Russo; Biagio Di Iorio
Journal:  Int J Nephrol       Date:  2011-04-07

3.  Predictors of quality of life of hemodialysis patients in India.

Authors:  I Veerappan; R M Arvind; V Ilayabharthi
Journal:  Indian J Nephrol       Date:  2012-01

4.  The beneficial impact of vitamin D treatment in CKD patients: what's next?

Authors:  Luigi Francesco Morrone; Mario Cozzolino
Journal:  Clin Kidney J       Date:  2014-12-13

5.  Targets for parathyroid hormone in secondary hyperparathyroidism: is a "one-size-fits-all" approach appropriate? A prospective incident cohort study.

Authors:  Emmanuelle Laurain; Carole Ayav; Marie-Line Erpelding; Michèle Kessler; Serge Briançon; Laurent Brunaud; Luc Frimat
Journal:  BMC Nephrol       Date:  2014-08-13       Impact factor: 2.388

6.  Ultrapure dialysis water obtained with additional ultrafilter may reduce inflammation in patients on hemodialysis.

Authors:  Biagio Di Iorio; Lucia Di Micco; Dario Bruzzese; Luca Nardone; Luigi Russo; Pietro Formisano; Vittoria D'Esposito; Domenico Russo
Journal:  J Nephrol       Date:  2017-08-23       Impact factor: 3.902

7.  Effects of parathyroid hormone and vitamin D supplementation on stroke among patients receiving peritoneal dialysis.

Authors:  Xiaohan You; Ying Zhou; Jianna Zhang; Qiongxiu Zhou; Yanling Shi; Zhen Su; Chaoshen Chen; Rongrong Shao; Ji Zhang
Journal:  BMC Nephrol       Date:  2020-05-18       Impact factor: 2.388

Review 8.  Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis.

Authors:  Jaime L Natoli; Rob Boer; Brian H Nathanson; Ross M Miller; Silvia Chiroli; William G Goodman; Vasily Belozeroff
Journal:  BMC Nephrol       Date:  2013-04-17       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.